A detailed history of Kfg Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kfg Wealth Management, LLC holds 1,636 shares of ABBV stock, worth $287,248. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,636
Previous 1,618 1.11%
Holding current value
$287,248
Previous $277,000 16.61%
% of portfolio
0.09%
Previous 0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $2,949 - $3,587
18 Added 1.11%
1,636 $323,000
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $1,547 - $1,807
-10 Reduced 0.61%
1,618 $277,000
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $1,598 - $1,821
10 Added 0.62%
1,628 $296,000
Q4 2023

Jan 31, 2024

SELL
$137.6 - $154.97 $8,393 - $9,453
-61 Reduced 3.63%
1,618 $250,000
Q3 2023

Oct 17, 2023

SELL
$133.59 - $154.65 $534 - $618
-4 Reduced 0.24%
1,679 $250,000
Q4 2022

Jan 18, 2023

BUY
$138.31 - $165.87 $232,775 - $279,159
1,683 New
1,683 $272 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kfg Wealth Management, LLC Portfolio

Follow Kfg Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kfg Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kfg Wealth Management, LLC with notifications on news.